5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
SELL | BUY | BUY | NEUTRAL | BUY |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 3.95▼ | 3.98▼ | 3.98▼ | 3.92▼ | 3.88▼ |
MA10 | 4.01▼ | 3.93▼ | 3.93▼ | 3.94▼ | 3.72▲ |
MA20 | 3.91▼ | 3.87▲ | 3.87▲ | 3.90▼ | 3.64▲ |
MA50 | 3.72▲ | 3.71▲ | 3.74▲ | 3.66▲ | 3.17▲ |
MA100 | 3.76▲ | 3.63▲ | 3.61▲ | 3.57▲ | N/A |
MA200 | 3.52▲ | 3.30▲ | 3.22▲ | 3.20▲ | N/A |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | -0.014▼ | 0.001▲ | 0.000▼ | -0.017▼ | 0.010▲ |
RSI | 50.354▲ | 53.199▲ | 53.315▲ | 50.096▲ | 57.995▲ |
STOCH | 41.615 | 68.478 | 68.478 | 39.144 | 79.859 |
WILL %R | -84.615▼ | -44.594 | -44.594 | -54.762 | -28.485 |
CCI | -65.956 | 13.976 | 14.068 | -51.206 | 51.287 |
MA | $EPRX Price Crossed Below MA(26) | Set Alert |
Monday, June 02, 2025 03:30 PM
Eupraxia Pharmaceuticals Inc. (“Eupraxia” or the “Company”) (TSX: EPRX) (NASDAQ: EPRX), a clinical-stage biotechnology company leveraging its proprietary DiffuSphere™ technology designed to optimize ...
|
Monday, June 02, 2025 03:30 PM
VICTORIA, British Columbia, June 02, 2025 (GLOBE NEWSWIRE) -- Eupraxia Pharmaceuticals Inc. (“Eupraxia” or the “Company”) (TSX: EPRX) (NASDAQ: EPRX), a ...
|
Sunday, May 11, 2025 05:00 PM
Eupraxia Pharmaceuticals (NASDAQ:EPRX – Get Free Report) will likely be posting its quarterly earnings results before the market opens on Wednesday, May 14th.Analysts expect Eupraxia ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
13/06/25 | 3.904 | 3.95 | 3.85 | 3.86 | 4,400 |
12/06/25 | 3.91 | 3.96 | 3.88 | 3.885 | 13,527 |
11/06/25 | 3.99 | 4.00 | 3.88 | 3.928 | 16,800 |
09/06/25 | 3.92 | 4.01 | 3.85 | 3.97 | 20,600 |
06/06/25 | 3.93 | 3.95 | 3.90 | 3.94 | 11,000 |
05/06/25 | 3.891 | 3.94 | 3.891 | 3.94 | 9,500 |
04/06/25 | 4.05 | 4.09 | 3.97 | 3.97 | 796 |
03/06/25 | 3.8995 | 4.09 | 3.875 | 4.065 | 6,475 |
02/06/25 | 3.94 | 3.95 | 3.85 | 3.94 | 11,572 |
30/05/25 | 3.8173 | 3.9062 | 3.8173 | 3.88 | 1,975 |
|
|
||||
|
|
||||
|
|